MedPath

Nutritional Study of Fish Oil in Skin Quality in Healthy Women

Not Applicable
Conditions
Skin Health
Registration Number
NCT05128240
Lead Sponsor
Epax Norway AS
Brief Summary

The skin acts as a barrier against the external environment and prevents water loss from the body. Aging is a natural process leading to changes in the skin and fish oil has been shown to prevent inflammation, hyperpigmentation and UV-damage. This pilot study will determine skin characteristics after intervention with north atlantic fish oil.

Detailed Description

Women will be recruited to a placebo or fish oil group and be examined at pre- and post for skin quality parameters such as wrinkles, fine lines and trans-epithelial water loss.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
30
Inclusion Criteria

Healthy women in the age of 30-65

Able to follow the following dietary restriction for 4 months (4 weeks wash-out, 3 months intervention):

  • Do not take omega-3 supplements
  • do not take supplements containing vitamin A
  • do not take supplements containing collagen
  • try to avoid using skin products containing vitamin A
  • do not undergo skin treatment
Exclusion Criteria

Pregnancy or breast feeding known allergy to seafood skin treatment the last 6 months planned skin treatment during the study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Determine the change in skin quality of healthy women after supplementation with fish oil compared to corn oil3 months

Changes in quantitative analysis of facial inflammation, wrinkles and fine lines and skin texture will be performed using the VISIA Skin Analysis system. Measurements will be made at baseline and at end of supplementation period.

Secondary Outcome Measures
NameTimeMethod
Determine the change in omega-3 index (%EPA and DHA in red blood cells) after daily intake of 4g of north atlantic fish oil compared to placebo3 months

Fatty acid profiles will be measured from blood samples using the Omega-quant test

Trial Locations

Locations (1)

Møreforsking AS

🇳🇴

Ålesund, Norway

Møreforsking AS
🇳🇴Ålesund, Norway
Lise Midtbø, PhD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.